肌抑素拮抗劑的用途、含有它們的組合及其用途

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

KLICKSTEIN, Lloyd B.,ROUBENOFF, Ronenn,FEIGE, Jerome,TRIFILIEFF, Estelle,HAKATEYAMA, Shinji

申请号：

HK18113597

公开号：

HK1254630A1

申请日:

2018.10.24

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

The present invention relates to myostatin antagonists, for the treatment of cancer cachexia, and cancer cachexia due to chemotherapeutic treatment Especially, the myostatin antagonist bimagrumab was found to be beneficial in the treatment of cancer cachexia by reducing body weight loss. The present invention also relates to combinations and uses of a myostatin antagonist and an mTOR inhibitor for treating cancer cachexia by reducing, maintaining or increasing body weight loss or for use in treating age-related conditions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/